The future of the global acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets. The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the acute spinal cord injury
market by type (complete spinal cord injury and incomplete spinal cord injury),
end use (hospitals and trauma centers), and region (North America, Europe, Asia
Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, complete
spinal cord injury and incomplete spinal cord injury are the major segments of
acute spinal cord injury market by type. Lucintel forecasts that incomplete
spinal cord injury (ISCI) will remain the larger segment over the forecast
period due to increasing incidence of spinal cord injuries and growing
awareness towards treatment of spinal cord injuries.
Within this market,
hospital is expected to remain the larger segment due to growing number of
inpatient rehabilitation programs at hospitals to deliver comprehensive
services to help people.
North America will
remain the largest region due to surge in aging population, well-developed
healthcare system, and increasing adoption of advanced technologies in the
region.
Novartis, Tenax
Therapeutics, Accure Pharma, Acorda Therapeutics, Asterias Biotherapeutics,
Renetx Bio, Bioarctic, Biotime, Invivo Therapeutics, and Kringle Pharma are the
major suppliers in the acute spinal cord injury market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment